Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 1;203(5):651.
doi: 10.1164/rccm.202011-4044LE.

Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease

Miguel Angel Martinez-Garcia  1   2 , Alvar Agustí  2   3   4
Affiliations
Comment

Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease

Miguel Angel Martinez-Garcia et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S, et al. The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study: a randomized, double-blind, multicenter clinical trial. Am J Respir Crit Care Med. 2020;202:1237–1243. - PMC - PubMed
    1. Suissa S. Inhaled corticosteroid withdrawal in chronic obstructive pulmonary disease: can IMPACT help? Am J Respir Crit Care Med. 2020;202:1202–1204. - PMC - PubMed
    1. Han MK, Lipson DA, Singh D, Martinez FJ. One more time: the impact of inhaled corticosteroid withdrawal on IMPACT. Am J Respir Crit Care Med. 2020;202:1205–1206. - PMC - PubMed
    1. Calverley P Angels dancing on the tip of a needle: interpreting clinical trials in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020;202:1206–1207. - PMC - PubMed
    1. Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, et al. IMPACT Investigators. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378:1671–1680. - PubMed

MeSH terms

Substances